The global Injection Pen Market was valued at USD 40.6 billion in 2023 and is projected to reach USD 73.8 billion by 2032, growing at a CAGR of 6.8% from 2024 to 2032. This growth is primarily driven by the increasing prevalence of chronic diseases such as diabetes, osteoporosis, cardiovascular conditions, and multiple sclerosis, which require regular and convenient drug administration.